Market Cap

China Resources Pharmaceutical Group Ltd Market Capitalization:

HK$35.87 Billion

HKD as of July 1, 2024

US$4.59 Billion

business China Resources Pharmaceutical Group Ltd Company Profile

China Resources Pharmaceutical Group Ltd Main Stock Listing

HKEX: 3320

Market Capitalization History of China Resources Pharmaceutical Group Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of China Resources Pharmaceutical Group Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 HK$34.24 B -13.61%
Jan. 1, 2023 HK$39.63 B 65.17%
Jan. 1, 2022 HK$23.99 B -7.11%
Jan. 1, 2021 HK$25.83 B -37.52%
Jan. 1, 2020 HK$41.34 B -41.38%
Jan. 1, 2019 HK$70.53 B 8.16%
Jan. 1, 2018 HK$65.21 B 22.04%
Jan. 1, 2017 HK$53.43 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

China Resources Pharmaceutical Group Ltd Categories

Hong Kong languages Healthcare languages Drug Manufacturers—Specialty & Generic
Hong Kong Healthcare Hong Kong Drug Manufacturers—Specialty & Generic

Stocks & Indices

China Resources Pharmaceutical Group Ltd has the following listings and related stock indices.


Stock: HKEX: 3320

Stock: FSX: 640

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.